Pivampicillin
From Wikipedia, the free encyclopedia
|
Pivampicillin
|
|
| Systematic (IUPAC) name | |
| 2,2-dimethylpropanoyloxymethyl (2S,5R,6R)- 6-{[(2R)-2-amino-2-phenyl-acetyl]amino}-3,3- dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0] heptane-2-carboxylate |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C22H29N3O6S |
| Mol. mass | 463.548 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | Renal (76%) |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Pivampicillin is a pivaloyloxymethylester of ampicillin. It is a prodrug, which is thought to enhance the oral bioavailability of ampicillin because of its greater lipophilicity compared to that of ampicillin.
|
|||||||||||

